| Year ended | Year ended | ||
$ million | Notes | 31 December 2025 | 31 December 2024 |
Revenue | 3 | ||
Cost of sales | ( | ( | |
Gross profit | |||
Other income | |||
Research and development expenses | 4 | ( | ( |
Administrative expenses | 5 | ( | ( |
Operating profit | |||
Finance income | 8 | ||
Finance cost | 8 | ( | ( |
Profit before taxation | |||
Taxation charge | 9 | ( | ( |
Profit for the year | |||
Operating profit | |||
Amortisation and depreciation | 7 | ||
EBITDA | |||
Employee share schemes | 29 | ||
Non-recurring costs | 5 | ||
Adjusted EBITDA | |||
| Earnings per share (cents) | |||
Basic | 10 | ||
Diluted | 10 |
$ million | Notes | 2025 | 2024 |
| Assets | |||
Intangible assets | 11 | ||
Property, plant and equipment | 12 | ||
Right-of-use assets | 13 | ||
Other non-current assets | 14 | ||
Total non-current assets | |||
Inventories | 15 | ||
Trade and other receivables | 16 | ||
Current tax receivables | 16 | ||
Cash and cash equivalents | 17 | ||
Other financial assets | 23 | ||
Total current assets | |||
Total assets | |||
| Liabilities | |||
Trade and other payables | 18 | ( | ( |
Provisions | 19 | ( | ( |
Lease liabilities | 21 | ( | ( |
Total current liabilities | ( | ( | |
Provisions | 19 | ( | ( |
Other non-current liabilities | 20 | ( | ( |
Lease liabilities | 21 | ( | ( |
Deferred tax liabilities | 25 | ( | ( |
Total non-current liabilities | ( | ( | |
Total liabilities | ( | ( | |
Net assets |
| At 31 December | At 31 December | ||
$ million | Notes | 2025 | 2024 |
| Shareholders’ equity | |||
Share capital | 26 | ||
Share premium | 26 | ||
Merger reserve | 26 | ( | ( |
Share-based payments | 27 | ||
Retained earnings | 26 | ||
Total shareholders’ equity |
| Share | Share | Share-based | Merger | Retained | |||
$ million | Notes | capital | premium | payments | reserve | earnings | Total |
At 1 January 2024 | |||||||
Profit for the year | |||||||
Share-based payments | 27 | ||||||
Shares issued | |||||||
Share reorganisation | A | ( | ( | ||||
Share capital reduction | A | ( | |||||
Share listing proceeds | B | ||||||
Share issuance costs | B | ( | ( | ||||
Share scheme settlement | ( | ||||||
At 31 December 2024 | 26 | ( | |||||
Profit for the year | |||||||
Share-based payments | 27 | ( | |||||
Exercise of share awards | ( | ||||||
VAT recovered on IPO-related share issuance costs | C | ||||||
At 31 December 2025 | 26 | ( |
| Year ended | Year ended | ||
$ million | Notes | 31 December 2025 | 31 December 2024 |
| Cash flows from operating activities | |||
Operating profit | |||
| Adjustments for: | |||
Amortisation and depreciation | 7 | ||
Gain on lease assignment | 13 | ( | |
Prepaid manufacturing charges | |||
Employee share schemes | 29 | ||
Research and development tax credit | ( | ( | |
Fair value gain on derivatives | ( | ||
(Decrease)/increase in provisions | ( | ||
(Increase)/decrease in trade and other receivables | ( | ||
Decrease/(increase) in inventories | ( | ||
(Decrease)/increase in trade and other payables | ( | ||
Cash flows from operating activities | ( | ||
Interest received | 8 | ||
Tax credit received | 16 | ||
Tax paid | 16 | ( | ( |
| Net cash flows generated from/(used in) | |||
operating activities | ( | ||
| Cash flows from investing activities | |||
Purchase of intangible assets | ( | ( | |
Purchase of property, plant and equipment | 12 | ( | ( |
Lease incentive received | 13 | ||
Capitalised initial direct costs on leases | ( | ||
Net cash used in investing activities | ( | ( |
| Year ended | Year ended | ||
$ million | Notes | 31 December 2025 | 31 December 2024 |
| Cash flows from financing activities | |||
Cash proceeds from IPO share issues | |||
Share issuance costs of IPO shares | ( | ||
Cash proceeds from share issues (from pre-IPO) | |||
Proceeds from share-based awards exercises | |||
Repayment of principal on lease liabilities | 21 | ( | ( |
Payment of interest on lease liabilities | 21 | ( | ( |
Cash paid for lease assignment | ( | ||
Settlement of IP licence payable | ( | ||
Interest and other financing charges | 8 | ( | ( |
| Net cash (used in)/generated from financing | |||
activities | ( | ||
| Net (decrease)/increase in cash and cash | |||
equivalents | ( | ||
Cash and cash equivalents at beginning of period | 17 | ||
| Effect of exchange rates on cash and cash | |||
equivalents | |||
Cash and cash equivalents | 17 |
| 2025 | 2025 | 2024 | 2024 | |||
| $ million | Capitalised | Total | % | Capitalised | Total | % |
Internal costs | 6.8 | 20.4 | 33% | 8.1 | 17.6 | 46% |
External costs | 6.7 | 8.8 | 76% | 12.5 | 14.6 | 86% |
| Directly | ||||||
| attributable R&D | ||||||
– cash | 13.5 | 29.2 | 46% | 20.6 | 32.2 | 64% |
Amortisation | 6.8 | 8.2 | 83% | 6.0 | 7.4 | 81% |
Depreciation | 0.3 | 1.3 | 23% | — | — | — |
| Total directly | ||||||
attributable R&D | 20.6 | 38.7 | 53% | 26.6 | 39.6 | 67% |
| Year ended | Year ended | |
| $ million – by category | 31 December 2025 | 31 December 2024 |
Products | 247.0 | 181.2 |
Components | 60.2 | 61.2 |
Royalties | 15.0 | 15.9 |
Other | 1.0 | 1.2 |
323.2 | 259.5 |
| Year ended | Year ended | |
| $ million – by customer location | 31 December 2025 | 31 December 2024 |
UK | 121.8 | 118.4 |
Europe | 64.3 | 48.1 |
Americas | 76.1 | 49.9 |
Asia Pacific | 59.2 | 40.8 |
Rest of the World | 1.8 | 2.3 |
323.2 | 259.5 |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Employee costs of internal engineers | 15.9 | 14.4 |
Employee share schemes | 4.5 | 3.2 |
Costs of external services and materials | 8.8 | 14.6 |
Intangibles amortisation | 13.6 | 12.3 |
Capitalised amortisation | (6.8) | (6.0) |
Capitalised research and development costs | (13.5) | (20.6) |
22.5 | 17.9 |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Employee costs | 11.5 | 8.7 |
Employee share schemes | 3.4 | 2.4 |
Other employee-related costs | 2.1 | 2.2 |
Professional fees | 3.7 | 3.2 |
Depreciation | 3.7 | 4.4 |
Property-related costs | 1.4 | 1.2 |
Other expenses | 1.8 | 2.7 |
Non-recurring costs | — | 2.9 |
27.6 | 27.7 |
| Year ended | Year ended | ||
| $ million | 31 December 2025 | 31 December 2024 | |
| Fees payable to the Group auditor for: | |||
• | the audit of the parent entity and consolidated | ||
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Wages and salaries | 22.8 | 19.0 |
Social security costs | 2.0 | 2.0 |
Pension costs | 1.8 | 1.4 |
Share-based payments | 8.7 | 4.7 |
Employee costs capitalised | (6.8) | (8.1) |
28.5 | 19.0 |
| Year ended | Year ended | |
| Average headcount | 31 December 2025 | 31 December 2024 |
Engineering | 67 | 66 |
Corporate and administrative | 22 | 16 |
Communications and publishing | 14 | 16 |
Sales and product management | 24 | 26 |
Retail | 7 | 10 |
134 |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Remuneration | 2.4 | 2.1 |
| Pension contributions to defined contribution pension | ||
scheme | 0.1 | — |
Share-based payments | 0.7 | 0.2 |
3.2 | 2.3 |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Depreciation of property, plant and equipment | 2.4 | 2.8 |
Depreciation of right-of-use assets | 1.6 | 1.6 |
Amortisation of intangible assets | 13.6 | 12.3 |
Plant and equipment depreciation capitalised | (0.3) | — |
Intangible amortisation capitalised | (6.8) | (6.0) |
10.5 | 10.7 |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
| Finance income | ||
Bank and other interest receivable | 1.0 | 1.1 |
| Finance costs | ||
Bank interest payable and similar charges | (1.0) | (0.8) |
Interest on lease liabilities | (0.4) | (0.4) |
Unwinding of discounts | (1.3) | (1.2) |
Foreign exchange | 0.2 | — |
(2.5) | (2.4) | |
Net financing items | (1.5) | (1.3) |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
| Current tax: | ||
Current taxation charge | 4.9 | 3.3 |
Adjustments in respect of previous periods | (1.8) | 0.1 |
3.1 | 3.4 | |
| Deferred tax: | ||
Deferred taxation charge | 1.4 | 1.6 |
Adjustment in respect of previous periods | 0.3 | (0.4) |
1.7 | 1.2 | |
Taxation charge for the year | 4.8 | 4.6 |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Profit before taxation | 26.5 | 16.3 |
Corporation tax at an effective rate of 25% (2024: 25%) | 6.6 | 4.1 |
| Effect of: | ||
Adjustments in respect of prior years | (1.5) | (0.3) |
Expenses not deductible for tax purposes | — | 0.8 |
Foreign exchange | (0.5) | — |
Share-based payments | 1.6 | — |
Effect of group relief/other reliefs | (1.4) | — |
Taxation charge for the year | 4.8 | 4.6 |
Earnings per share | 2025 | 2024 |
Profit after tax ($ million) | 21.7 | 11.7 |
Weighted average number of shares in issue during the period | 193,477,224 | 180,669,421 |
Shares held in Employee Benefit Trust | (155,226) | (155,226) |
Total number of shares for basic EPS | 193,321,998 | 180,514,195 |
Basic earnings per share (cents) | 11.22 | 6.48 |
Dilutive effect of legacy performance shares scheme | — | 7,638,832 |
Dilutive effect of post-IPO schemes | 3,935,355 | 546,798 |
Weighted average dilutive number of shares during the period | 197,257,353 | 188,699,825 |
Diluted earnings per share (cents) | 11.00 | 6.20 |
Adjusted earnings per share | 2025 | 2024 |
Profit after tax ($ million) | 21.7 | 11.7 |
Non-recurring costs – disallowable for tax ($ million) | — | 2.9 |
Employee share schemes ($ million) | 7.9 | 6.0 |
Tax on employee share schemes ($ million) | (1.6) | (1.3) |
Adjusted profit after tax ($ million) | 28.0 | 19.3 |
Total number of shares for basic EPS | 193,321,998 | 180,514,195 |
Adjusted basic earnings per share (cents) | 14.48 | 10.69 |
Weighted average dilutive number of shares in the period | 197,257,353 | 188,699,825 |
Adjusted diluted earnings per share (cents) | 14.19 | 10.23 |
| On-market | Pipeline | Other acquired | ||
| $ million | development | development | intangibles | Total |
| Cost | ||||
At 1 January 2024 | 25.7 | 21.2 | 21.1 | 68.0 |
Additions | — | 26.6 | 0.3 | 26.9 |
Transfers | 13.3 | (13.3) | — | — |
At 31 December 2024 | 39.0 | 34.5 | 21.4 | 94.9 |
Additions | — | 20.6 | 3.0 | 23.6 |
Transfers | 1.2 | (1.2) | — | — |
At 31 December 2025 | 40.2 | 53.9 | 24.4 | 118.5 |
| Amortisation | ||||
At 1 January 2024 | (7.9) | — | (1.5) | (9.4) |
Charge | (4.9) | — | (7.4) | (12.3) |
At 31 December 2024 | (12.8) | — | (8.9) | (21.7) |
Charge | (5.4) | — | (8.2) | (13.6) |
At 31 December 2025 | (18.2) | — | (17.1) | (35.3) |
| Net book value: | ||||
At 31 December 2025 | 22.0 | 53.9 | 7.3 | 83.2 |
At 31 December 2024 | 26.2 | 34.5 | 12.5 | 73.2 |
| External impairment triggers: Market decline, economic changes, increased competition, |
| technological obsolescence, interest rate shifts, and legal or political factors. |
| Internal impairment triggers: Underperformance, asset utilisation changes, physical |
| damage, restructuring, reduced useful life, and licensing or contractual issues. |
| Office and | ||||
| Leasehold | Plant and | computer | ||
| $ million | improvements | equipment | equipment | Total |
| Cost | ||||
At 1 January 2024 | 1.7 | 8.8 | 2.5 | 13.0 |
Additions | 0.5 | 1.2 | 0.5 | 2.2 |
At 31 December 2024 | 2.2 | 10.0 | 3.0 | 15.2 |
Additions | 0.1 | 1.5 | 0.2 | 1.8 |
At 31 December 2025 | 2.3 | 11.5 | 3.2 | 17.0 |
| Depreciation | ||||
At 1 January 2024 | (0.2) | (6.4) | (1.3) | (7.9) |
Charge | (0.5) | (1.7) | (0.6) | (2.8) |
At 31 December 2024 | (0.7) | (8.1) | (1.9) | (10.7) |
Charge | (0.4) | (1.3) | (0.7) | (2.4) |
At 31 December 2025 | (1.1) | (9.4) | (2.6) | (13.1) |
| Net book value: | ||||
At 31 December 2025 | 1.2 | 2.1 | 0.6 | 3.9 |
At 31 December 2024 | 1.5 | 1.9 | 1.1 | 4.5 |
$ million | 2025 | 2024 |
At 1 January | 6.1 | 6.7 |
Remeasurements | 4.5 | 1.0 |
Derecognition | (0.4) | — |
Depreciation | (1.6) | (1.6) |
8.6 | 6.1 |
$ million | 2025 | 2024 |
Prepaid manufacturing cost | 1.3 | 2.0 |
Deferred tax asset | 0.1 | 0.3 |
1.4 | 2.3 |
$ million | 2025 | 2024 |
Components | 114.1 | 92.9 |
Finished goods | 31.2 | 63.8 |
145.3 | 156.7 |
$ million | 2025 | 2024 |
Trade receivables | 52.6 | 31.0 |
Prepayments | 4.5 | 3.6 |
VAT receivable | 1.6 | 0.9 |
Other receivables | 0.8 | 0.7 |
59.5 | 36.2 |
$ million | 2025 | 2024 |
Current tax receivable | 1.4 | 6.6 |
$ million | 2025 | 2024 |
Cash at bank | 11.1 | 5.8 |
Money market deposits | 17.0 | 40.0 |
28.1 | 45.8 |
$ million | 2025 | 2024 |
Trade payables | 46.5 | 83.1 |
Accruals and other payables | 6.5 | 7.1 |
Repurchase liabilities | 5.9 | 4.4 |
Other taxation and social security | 1.2 | 1.0 |
Deferred income – RDEC | 0.5 | 0.5 |
60.6 | 96.1 |
$ million | 2025 | 2024 |
Less than one year | 0.3 | 0.7 |
Between one and five years | 0.9 | 1.9 |
1.2 | 2.6 |
| $ million | Property | Employee | Others | Total |
As at 1 January | 0.9 | 1.3 | 0.4 | 2.6 |
Additions | — | — | — | — |
Utilised | — | (0.1) | — | (0.1) |
Released | (0.3) | (0.8) | (0.2) | (1.3) |
0.6 | 0.4 | 0.2 | 1.2 |
$ million | 2025 | 2024 |
Deferred income – RDEC | 6.9 | 4.7 |
Licence payables | — | 1.3 |
6.9 | 6.0 |
$ million | 2025 | 2024 |
As at 1 January | 5.1 | 2.2 |
Estimate RDEC claim for the year | 2.8 | 3.6 |
Released to match incurred costs | (0.5) | (0.5) |
Released to match amortisation | — | (0.2) |
7.4 | 5.1 |
| $ million | 2025 | 2024 |
At 1 January | 6.2 | 7.1 |
Remeasurements | 4.5 | 1.0 |
Derecognition | (0.9) | — |
Interest | 0.4 | 0.4 |
Principal repayment | (1.1) | (2.2) |
Interest payment | (0.4) | (0.4) |
Foreign exchange | 0.2 | 0.3 |
8.9 | 6.2 |
$ million | 2025 | 2024 |
Less than one year | 0.8 | 1.4 |
Between one and five years | 6.1 | 5.2 |
Over five years | 4.9 | — |
11.8 | 6.6 | |
Effect of discounting | (2.9) | (0.4) |
8.9 | 6.2 |
$ million | 2025 | 2024 |
Trade receivables | 52.6 | 31.0 |
Cash and cash equivalents | 28.1 | 45.8 |
Financial assets at amortised cost due within one year | 80.7 | 76.8 |
Financial asset measured at FVTPL | 0.2 | — |
$ million | 2025 | 2024 |
Trade payables | 46.5 | 84.0 |
Other financial liabilities | 1.3 | 3.0 |
Financial liabilities at amortised cost due within one year | 47.8 | 87.0 |
Financial liabilities at amortised due over one year | — | 1.3 |
Financial liabilities at amortised cost | 47.8 | 88.3 |
$ million | 2025 | 2024 |
| Deferred tax liabilities | ||
Development costs capitalised | (15.7) | (13.1) |
Property, plant and equipment | (0.7) | (0.7) |
(16.4) | (13.8) | |
| Deferred tax assets | ||
Share-based payments | 0.9 | 2.1 |
Deferred income – RDEC | 1.9 | 1.3 |
Other timing differences | 0.4 | 0.3 |
3.2 | 3.7 | |
Net deferred tax liability | (13.2) | (10.1) |
| Nominal capital | ||
Share capital | Number of shares | $ million |
Ordinary shares of £0.0025 each | 193,582,149 | 0.6 |
Deferred shares of £0.0025 each | 61,610,435 | 0.2 |
255,192,584 | 0.8 |
| Market value | Restricted | Performance | ||
options | Nil cost | Share Units | Share Units | |
Outstanding at beginning of the year | 11,561,566 | 253,773 | — | — |
Granted during the year | — | — | 926,875 | 967,956 |
Forfeited during the year | (186,978) | — | (2,057) | — |
Exercised during the year | (46,768) | — | (119,666) | — |
Outstanding at end of the year | 11,327,820 | 253,773 | 805,152 | 967,956 |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Deferred Bonus Plan | 0.1 | — |
| Performance Share units and Restricted Share Units – | ||
granted on 14 May 2025 | 3.4 | — |
| Market value and nil-cost options – granted on 11 June | ||
2024 | 5.2 | 2.7 |
Legacy 2020 LTIP scheme – IFRS 2 charge | — | 0.8 |
Legacy 2020 LTIP scheme – accelerated charge on settlement | — | 1.2 |
8.7 | 4.7 |
| Restricted Share | |||||
TSR Performance Share Units | EPS Performance Share Units | Units | |||
| Post-vesting | |||||
holding period | None | 2 years | None | 2 years | None |
Grant date | 14 May 2025 | ||||
Number of awards | |||||
granted | 212,055 | 111,242 | 422,841 | 221,818 | 926,875 |
| Grant date | |||||
share price | £5.20 | ||||
Fair value of share | £4.25 | £3.59 | £5.20 | £4.39 | £5.20 |
Exercise price | — | — | — | — | £0.0025 |
Expected term | 2.6 years | 2.6 years | 2.6 years | 2.6 years | 4 years |
| Expected | |||||
volatility | 35.0% | 35.0% | 35.0% | 35.0% | n/a |
Risk-free rate | 3.90% | 3.90% | 3.90% | 3.90% | n/a |
Dividend yield | 0.0% | 0.0% | 0.0% | 0.0% | n/a |
| Adjusted | |||||
| grant date | |||||
| fair value | |||||
| Grant date | (post-vesting | Grant date fair | |||
Valuation type | Monte Carlo | Monte Carlo | fair value | restriction) | value |
Market value options | Nil cost | |
Grant date | 11 June 2024 | 11 June 2024 |
Number of awards granted | 11,561,566 | 253,773 |
Grant date share price | £2.80 | £2.80 |
Exercise price | £2.80 | £0.00 |
Expected term | 5 years | 3 years |
Expected volatility | 35.0% | 35.0% |
Risk-free rate | 4.2% | 4.4% |
Dividend yield | 0.0% | 0.0% |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Operating profit | 28.0 | 17.6 |
Amortisation and depreciation | 10.5 | 10.7 |
EBITDA | 38.5 | 28.3 |
Share-based payment charges | 8.7 | 4.7 |
NI on share-based payment charges | (0.8) | 1.3 |
Employee share schemes | 7.9 | 6.0 |
Non-recurring costs | — | 2.9 |
Adjusted EBITDA | 46.4 | 37.2 |
Amortisation and depreciation | (10.5) | (10.7) |
Adjusted operating profit | 35.9 | 26.5 |
| Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Research and development expenses | 22.5 | 17.9 |
Amortisation (net of capitalised amortisation) | (6.8) | (6.3) |
Share-based payment charges | (5.1) | (2.3) |
NI on share-based payment charges | 0.6 | (0.6) |
Adjusted research and development expenses | 11.2 | 8.7 |
Year ended | Year ended | |
| $ million | 31 December 2025 | 31 December 2024 |
Administrative expenses | 27.6 | 27.7 |
Depreciation (net of capitalised depreciation) | (3.7) | (4.4) |
Share-based payment charges | (3.6) | (2.4) |
NI on share-based payment charges | 0.2 | (0.7) |
Non-recurring costs | — | (2.9) |
Adjusted administrative expenses | 20.5 | 17.3 |